Channels - Association of autoimmune diseases with biologic agents targeting type 2 immunity: An observational study using a claims database :: FRELIP Discovery

Similar Items: Association of autoimmune diseases with biologic agents targeting type 2 immunity: An observational study using a claims database

Quick Look
Balancing the complex interplay between type 2 immunity‐targeting biologics and autoimmune phenomena in real‐world practice
Quick Look
Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
Quick Look
Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists
Quick Look
Real-World Effectiveness of Biologic and Targeted Synthetic Therapies in Rheumatoid Arthritis: a Multicenter Study from Rheumatoid Arthritis Saudi Database (RASD)
Quick Look
Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis
Quick Look
Epstein‐Barr virus as a driver of lupus: Rethinking triggers in autoimmunity
Quick Look
Type I interferon overactivation in sera of patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease
Quick Look
A Combined Transcriptomics and Proteomics Approach to Identify Immune Signatures in ANCA‐Associated Glomerulonephritis
Quick Look
From Nerve to Autoimmunity: Acute Guillain-Barré Syndrome in a 4-Year-Old with Early-Onset Pediatric Systemic Lupus Erythematosus
Quick Look
Biologic Therapy Is Associated with Faster Bone Union After the Sauvé–Kapandji Procedure in Patients with Rheumatoid Arthritis
Quick Look
The Risk of Developing Immune-Mediated Rheumatic Disease Among Adult Patients with Temporomandibular Disorders, a Retrospective Single-Center Cohort Study
Quick Look
Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis
Quick Look
Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time
Quick Look
Colchicine Inhibits Chemokine Production in Monosodium Urate–Stimulated Innate Immune Cells
Quick Look
Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study)
Quick Look
Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD)
Quick Look
Shingles vaccination before targeted therapy: why clear guidance isn’t enough
Quick Look
Causal relationship between immune cells and idiopathic thrombocytopenic purpura: A bidirectional Mendelian randomization study
Quick Look
Quantitative computed tomography in interstitial lung disease related to ANCA‐associated vasculitis: First insights from a mono‐centric retrospective cohort
Quick Look
Identification of Key Glycolysis-Related Genes in Osteoarthritis and Their Correlation with Immune Infiltration Using Bioinformatics Analysis and Machine Learning
Quick Look
Persistence Among Biologic/JAKi-Naive Medicare Beneficiaries with RA Initiating Synthetic DMARDs
Quick Look
Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti–β2‐Glycoprotein I Antibodies
Quick Look
Corrigendum “immune cell alterations in a pristane‐induced lupus model in C57BL/6J mice”
Quick Look
The prevalence of pulmonary airway lesions is high in HTLV-1-positive rheumatoid arthritis: a cross-sectional observational study